GO
Loading...

Pfizer Inc

More

  • AP Top Extended Financial Headlines At 7:11 a.m. EDT Tuesday, 30 Sep 2014 | 7:11 AM ET

    Ford shares fall as company says it no longer expects Europe profit in 2015 EU targets Apple's overseas tax model, says Ireland appears to grant firm illegal rebate Global stocks mostly higher after after Wall Street declines, Hong Kong protests Down at 0.3 percent in year to September, eurozone inflation stands at near five-year low China approves iPhone 6 after Apple promises no' backdoors'; Apple says sales start Oct. 17 Drugmaker Pfizer, aiming to raise sales of its Viagra, starts new ad campaign targeting women Using another bank's ATM keeps costing you more, an average of $4.35 for each transaction SEC says Bank of America will pay $7.65 M to end inquiry into errors in report to Fed US consumer spending climbed healthy 0.5 percent in August, while income up 0.3 percent Survey: China manufacturing growth in September holds steady at low level, exports improve

  • AP Top Extended Financial Headlines At 6:21 a.m. EDT Tuesday, 30 Sep 2014 | 6:21 AM ET

    Ford shares fall as company says it no longer expects Europe profit in 2015 EU targets Apple's overseas tax model, says Ireland appears to grant firm illegal rebate Global stocks mostly higher after after Wall Street declines, Hong Kong protests Down at 0.3 percent in year to September, eurozone inflation stands at near five-year low China approves iPhone 6 after Apple promises no' backdoors'; Apple says sales start Oct. 17 Drugmaker Pfizer, aiming to raise sales of its Viagra, starts new ad campaign targeting women Using another bank's ATM keeps costing you more, an average of $4.35 for each transaction SEC says Bank of America will pay $7.65 M to end inquiry into errors in report to Fed US consumer spending climbed healthy 0.5 percent in August, while income up 0.3 percent Survey: China manufacturing growth in September holds steady at low level, exports improve

  • Viagra ads target women for 1st time Tuesday, 30 Sep 2014 | 5:02 AM ET

    TRENTON, N.J.— The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial that targets the less-obvious sufferers of the sexual condition: women. Having a woman speak directly to men about impotence is a unique strategy for Pfizer Inc. The world's second-biggest drugmaker is looking for ways to...

  • Drug and device firms paid $3.5B to care providers Tuesday, 30 Sep 2014 | 2:44 AM ET

    WASHINGTON— From research grants to travel junkets, drug and medical device companies paid doctors and leading hospitals billions of dollars last year, the government disclosed Tuesday in a new effort to spotlight potential ethical conflicts in medicine. The value of industry payments and other financial benefits totaled nearly $3.5 billion in the...

  • Final Glance: Pharmaceuticals companies Monday, 29 Sep 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 40 or. 6 percent, to $71.88. Bristol-Myers Squibb Co. rose$. 61 or 1.2 percent, to $51.71. Hospira rose$. 54 or 1.0 percent, to $52.75.

  • Midday Glance: Pharmaceuticals companies Monday, 29 Sep 2014 | 1:51 PM ET

    Baxter International Inc. fell$. 41 or. 6 percent, to $71.87. Bristol-Myers Squibb Co. rose$. 61 or 1.2 percent, to $51.71. Hospira rose$. 24 or. 5 percent, to $52.45.

  • Most active New York Stock Exchange-traded stocks Monday, 29 Sep 2014 | 1:51 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Advanced Micro Devices Inc. fell 1.4 percent to $3.55 with 26,783,600 shares traded. Athlon Energy Inc. rose 24.8 percent to $58.32 with 31,821,300 shares traded.

  • Early Glance: Pharmaceuticals companies Monday, 29 Sep 2014 | 10:36 AM ET

    Baxter International Inc. fell$. 36 or. 5 percent, to $71.92. Hospira fell$. 25 or. 5 percent, to $51.96. Johnson& Johnson fell$. 94 or. 9 percent, to $106.16.

  • *AstraZeneca says tolerability profile encouraging. MADRID, Sept 27- Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system show the cocktail is promising, though limited patient numbers mean the data is far from conclusive.

  • Sept 27- Pfizer Inc's Xalkori, which treats lung cancer patients with a specific gene mutation, proved effective in shrinking tumors in those with an even rarer form of the disease, according to data presented at a medical meeting on Saturday.

  • *AstraZeneca says tolerability profile encouraging. MADRID, Sept 27- Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system suggest the cocktail is promising, though limited patient numbers mean the data is far from conclusive.

  • Midday Glance: Pharmaceuticals companies Friday, 26 Sep 2014 | 1:17 PM ET

    Baxter International Inc. rose$. 75 or 1.1 percent, to $72.03. Bristol-Myers Squibb Co. fell$. 79 or 1.5 percent, to $50.83. Hospira fell$. 03 or. 1 percent, to $52.00.

  • Most active New York Stock Exchange-traded stocks Friday, 26 Sep 2014 | 1:17 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Alcoa Inc. rose 2.9 percent to $16.08 with 11,206,000 shares traded. Alpha Natural Resources Inc. fell 2.9 percent to $2.36 with 10,526,100 shares traded.

  • Early Glance: Pharmaceuticals companies Friday, 26 Sep 2014 | 11:12 AM ET

    Baxter International Inc. rose$. 86 or 1.2 percent, to $72.14. Bristol-Myers Squibb Co. fell$. 13 or. 2 percent, to $51.50. Johnson& Johnson fell$. 13 or. 1 percent, to $106.98.

  • Final Glance: Pharmaceuticals companies Thursday, 25 Sep 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 88 or 1.2 percent, to $71.28. Bristol-Myers Squibb Co. fell$. 34 or. 7 percent, to $51.62. Hospira fell $1.01 or 1.9 percent, to $52.03.

  • Midday Glance: Pharmaceuticals companies Thursday, 25 Sep 2014 | 1:24 PM ET

    Baxter International Inc. fell$. 80 or 1.1 percent, to $71.36. Bristol-Myers Squibb Co. fell$. 37 or. 7 percent, to $51.59. Hospira fell$. 89 or 1.7 percent, to $52.15.

  • Most active New York Stock Exchange-traded stocks Thursday, 25 Sep 2014 | 1:24 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 9 percent to $35.08 with 19,634,100 shares traded. Alpha Natural Resources Inc. fell 4.7 percent to $2.43 with 22,160,300 shares traded.

  • Early Glance: Pharmaceuticals companies Thursday, 25 Sep 2014 | 11:40 AM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $71.66. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $51.86. Hospira fell$. 33 or. 6 percent, to $52.71.

  • Final Glance: Pharmaceuticals companies Wednesday, 24 Sep 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 44 or. 6 percent, to $72.16. Bristol-Myers Squibb Co. rose$. 67 or 1.3 percent, to $51.96. Hospira rose$. 90 or 1.7 percent, to $53.04.

  • AP Top Extended Financial Headlines At 1:39 p.m. EDT Wednesday, 24 Sep 2014 | 1:39 PM ET

    US judge: Businesses don't have to give back millions of dollars in BP oil spill payouts From day care and health care to housing and college, US middle class feeling tighter squeeze US new-home sales up 18 percent in August as West and Northeast drive buying US stocks move higher after three days of declines; Bed Bath& Beyond rises on earnings gain Embattled BlackBerry launches new large screen, square sized smartphone Trade-off: Small businesses drop health insurance, pay employees to buy own coverage S. Korea to buy 40 F-35A fighter jets from Lockheed Martin in largest weapons purchase project Inovio Pharma say its wants to start human testing of DNA-based Ebola vaccine in early 2015 GM says China sales this year to top 3.1 million, sees no impact from anti-monopoly probe Pfizer will ask FDA to remove "black box" suicide warning from its anti-smoking medication